_1777352244987_250242181.png&w=64&q=75){kind=small}
_1777352142843_145525226.png&w=64&q=75){kind=small}
Pharma Dept. Confirms Price Rise Outlook to 2026
The head of the Pharmaceuticals Department at the Chamber of Commerce confirmed that the pharmaceutical market in Egypt is currently experiencing a relative stability in prices. There are no plans to increase the current medicine prices until the end of 2026, unless there are changes in the dollar exchange rate that meet the specified review conditions. He clarified that any adjustments to new medicine prices are based on a formula that depends on the dollar rate at 60%, inflation at 30%, and bank interest rates at 10%. Any anticipated increase is expected to range between 12% and 13% if the conditions are met. He also emphasized that a decrease in the dollar price could lead to lower prices for some medications. Currently, the Egyptian market is better than in 2024, with alternatives available for rare or scarce medicines, with reductions reaching up to 60% for some drugs. Additionally, he advised patients not to insist on a specific brand name if it is unavailable and to consult their doctor or pharmacist to find suitable alternatives containing the same active ingredient.
Notice: This Is an AI-Generated Summary
Comments (0)